Portside Wealth Group’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.12M Sell
8,077
-77
-0.9% -$20.3K 0.23% 93
2026
Q2
$1.8M Sell
8,154
-511
-6% -$141K 0.21% 110
2026
Q1
$2.56M Buy
8,665
+2,303
+36% +$684K 0.35% 68
2025
Q4
$1.74M Buy
6,362
+1,264
+25% +$343K 0.23% 100
2025
Q3
$1.38M Buy
5,098
+608
+14% +$165K 0.19% 119
2025
Q2
$1.24M Buy
4,490
+216
+5% +$58.7K 0.18% 124
2025
Q1
$1.13M Buy
4,274
+396
+10% +$97.7K 0.18% 124
2024
Q4
$901K Buy
3,878
+30
+0.8% +$6.9K 0.15% 149
2024
Q3
$849K Buy
3,848
+1,368
+55% +$283K 0.15% 159
2024
Q2
$488K Buy
+2,480
New +$512K 0.09% 216

Other funds holding CME

Portside Wealth Group's CME Position: Q3 2026 in Review

Portside Wealth Group reduced its CME Group (CME) stake by 0.94% in Q3 2026, selling an estimated $20.3K and leaving 8,077 shares worth $2.12M. The position accounts for 0.23% of the portfolio, ranked #93.

Portside Wealth Group first reported a position in CME in Q2 2024 and has held it in 10 quarters since. The position peaked at $2.56M in Q1 2026. 382 funds tracked by Wall St. Rank hold CME as of Q3 2026.

  • Portside Wealth Group held 8,077 shares of CME Group worth $2.12M as of Q3 2026.
  • Portside Wealth Group sold 77 CME Group shares in Q3 2026, an estimated $20.3K.
  • CME Group made up 0.23% of Portside Wealth Group's portfolio in Q3 2026, its #93 holding.
  • Portside Wealth Group first reported a position in CME Group in Q2 2024 and has held it in 10 quarters since.
  • Portside Wealth Group's CME Group position peaked at $2.56M in Q1 2026.
  • 382 funds tracked by Wall St. Rank held CME Group as of Q3 2026.

Based on Portside Wealth Group's 13F filing for Q3 2026, filed 20 Oct 2026.